◀ Back to IRF6

IRF6 — JAK1

Text-mined interactions from Literome

Stoiber et al., J Immunol 1999 : A causal link of decreased IFN-gamma signaling to SOCS3 induction was also suggested by the LPS dependent reduction of IFN-gamma mediated Janus kinase 1 (JAK1) activation
Severgnini et al., Am J Physiol Lung Cell Mol Physiol 2004 (Acute Disease...) : We also demonstrated that LPS activates both the STAT kinases, Src and JAK , in the lung with kinetics that are consistent with STAT activation
Liu et al., Zhonghua Shao Shang Za Zhi 2005 : In addition, the cells were divided into normal control, LPS stimulation, JAK2 inhibition ( with AG490 treatment 2 hours before LPS stimulation ), STAT1 inhibition ( with fludarabine treatment 2 hours before LPS stimulation ) and STAT3 inhibition ( with rapamycin treatment 2 hours before LPS stimulation ) groups
Wu et al., Br J Pharmacol 2009 : Effects of tripterine were investigated on endothelial barrier function, inducible nitric oxide synthase (iNOS) expression, nicotinamide adenine dinucleotide phasphate ( NADPH ) oxidase activity, 3-nitrotyrosine formation, protein phosphatase type 2A (PP2A) activity, activation of extracellular regulated kinase (ERK), c-Jun terminal kinase (JNK) and Janus kinase ( Jak2 ), and degradation of IkappaB in microvascular endothelial cells exposed to pro-inflammatory stimulus [ lipopolysaccharide (LPS) + interferon gamma (IFNgamma) ] and on vascular permeability in air pouches of mice injected with LPS + IFNgamma
Gorina et al., Glia 2011 : LPS also induced delayed Jak1/Stat1 activation, which was MyD88 independent but was not mediated by IFN-ß